Related Experiment Video
Updated: Aug 13, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Neurocognitive testing supports a broader concept of mild cognitive impairment
C Thomas Gualtieri1, Lynda G Johnson
1C. Thomas Gualtieri, MD, Medical Director, North Carolina Neuropsychiatry Clinics, Chapel Hill/Charlotte, North Carolina, USA.
Abstract:
The narrow concept of mild cognitive impairment (MCI) as an early form of Alzheimer s disease has been broadened by research that established the existence of alternative forms of the condition that may presage other forms of dementia. The research presented here was a naturalistic, cross-sectional study of patients in a community referral clinic-patients with MCI and mild dementia-compared to normal controls. A comprehensive, computerized neurocognitive screening battery developed by one of the authors (CNS Vital Signs) was administered to all of the subjects. Participants consisted of 36 patients with MCI and 53 patients with mild dementia, diagnosed by standard criteria, and 89 matched normal controls. Multivariate analysis indicated significant differences among the three groups for all 15 primary test variables and for all five of the domain scores. Tests of memory, processing speed, and cognitive flexibility were the most cogent discriminators between normal controls and MCI patients, and between MCI patients and patients with mild dementia. The same three tests also had the greatest sensitivity and specificity. The results of this study indicate that computerized testing can differentiate among normal controls, MCI patients, and patients with mild dementia. Also, in a diverse group of MCI and mild dementia patients, impairments in memory, processing speed, and cognitive flexibility were the most prominent observed deficits.
Insights
Computerized cognitive tests effectively distinguish between normal cognition, mild cognitive impairment (MCI), and mild dementia. Memory, processing speed, and cognitive flexibility are key indicators differentiating these groups.
Area of Science:
- Neuroscience
- Gerontology
- Cognitive Psychology
Background:
- Mild cognitive impairment (MCI) is increasingly recognized beyond its association with Alzheimer's disease.
- Research indicates MCI can precede various forms of dementia.
- Understanding diagnostic markers for MCI and mild dementia is crucial for early intervention.
Purpose of the Study:
- To evaluate the efficacy of a computerized neurocognitive screening battery in differentiating between normal controls, MCI patients, and mild dementia patients.
- To identify specific cognitive domains and tests most sensitive in distinguishing these groups.
Main Methods:
- A naturalistic, cross-sectional study involving 89 normal controls, 36 MCI patients, and 53 mild dementia patients.
- Administration of a comprehensive, computerized neurocognitive screening battery (CNS Vital Signs).
- Multivariate analysis to compare performance across the three groups.
Main Results:
- Significant differences were found among all three groups across 15 primary test variables and 5 domain scores.
- Tests of memory, processing speed, and cognitive flexibility demonstrated the highest sensitivity and specificity.
- These specific tests were the most effective in discriminating between normal controls and MCI, and between MCI and mild dementia.
Conclusions:
- Computerized neurocognitive testing is a viable tool for differentiating between normal cognition, MCI, and mild dementia.
- Deficits in memory, processing speed, and cognitive flexibility are prominent in individuals with MCI and mild dementia.
- These findings support the use of targeted cognitive assessments for early detection and diagnosis of cognitive decline.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
The progression of dementia is generally gradual.
Language and Cognition